Firms Await Brazilian Regulator’s Decision On Allowing ‘Skinny Labels’ For Generics

 
• By Ian Schofield
  
Should Brazil allow generic medicine packs to omit indications still under patent? • Source: Shutterstock

More from Legal & IP

More from Pink Sheet